Equity Overview
Price & Market Data
Price: $0.405
Daily Change: +$0.0217 / 5.36%
Daily Range: $0.375 - $0.41
Market Cap: $31,712,856
Daily Volume: 135,358
Performance Metrics
1 Week: 4.17%
1 Month: -54.30%
3 Months: -52.88%
6 Months: -62.61%
1 Year: -63.29%
YTD: -57.88%
Company Details
Employees: 32
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.